论文部分内容阅读
目的：探讨脑利钠肽注射液对充血性心力衰竭的治疗效果。方法选取我院2013年1月至2014年9月的充血性心力衰竭患者共98例作为研究对象，将其分为对照组45例与治疗组53例，对照组采取常规治疗的治疗方法，治疗组在常规治疗的基础上加以脑利钠肽注射液治疗，观察其治疗后临床表现等，并作统计分析。结果两组患者经治疗后，对照组NT-PORBNP水平治疗前后为（4450.2±2546.1）pg/ml和（3440.9±1873.1）pg/ml，治疗组中NT-PORBNP水平治疗前后为（5941.9±2794.1）pg/ml和（1971.7±1178.1）pg/ml；对照组治疗总有效例数为35例，治疗总有效率为77.7%，治疗组中总有效例数为53例，治疗总有效率达到了96.2%。结论在常规治疗的基础上加以脑利钠肽注射液治疗充血性心力衰竭，疗效显著，值得临床推广并使用。“,”Objective To investigate the brain natriuretic peptide injection for the treatment of congestive heart failure. Selection. Methods From January 2013 to September 2014, a total of 98 patients with congestive heart failure as the research object, it can be divided into control group 45 cases and 53 cases in treatment group and control group treated with conventional treatment, the treatment group on the basis of conventional treatment to brain natriuretic peptide injection treatment, observe its clinical symptoms after treatment, etc., and statistical analysis. Results Two groups of patients after treatment, the control group the NT-PORBNP levels before and after treatment for pg/ml (4450.2-2546.1) and (3440.9 + 1873.1) pg/ml, NT - PORBNP level before and after treatment in treatment group for pg/ml (5941.9-2794.1) and (1971.7+1178.1) pg/ml;The control group total effective treatment cases for 35 cases, treatment the total effective rate was 77.7%, total effective cases in treatment group of 53 cases, total effective rate was 100%. Conclusion On the basis of conventional treatment to brain natriuretic peptide injection in the treatment of congestive heart failure, curative effect is distinct, worthy of clinical promotion and use.